Renaissance Capital logo

Esperion Therapeutics Priced, Nasdaq: ESPR

Developing a treatment for elevated levels of low-density lipoprotein cholesterol.

Industry: Health Care

First Day Return: +3.6%

Industry: Health Care

Developing a treatment for elevated levels of low-density lipoprotein cholesterol.
more less

Esperion Therapeutics (ESPR) Performance